Register
Login:
Share:
Email Facebook Twitter




SAR Share Chat - RSS Feed

Sareum Share Chat (SAR)



Share Price: 0.35Bid: 0.30Ask: 0.40Change: 0.00 (0.00%)No Movement on Sareum
Spread: 0.10Spread as %: 33.33%Open: 0.35High: 0.375Low: 0.335Yesterday’s Close: 0.35


Share Discussion for Sareum (SAR)


Thread ViewThread View
Please Login or Register to post messages
Posts per page:


Premium Membership
Hopkirk
Posts: 1,218
Off Topic
Opinion:No Opinion
Price:0.48
View Thread (2)
PCS1954
8 May '14
Hi. True. Maybe BACIT will pay the lions share reducing SARs fundraising requirements but my suspicion is that its all equal and any reduction of payments at this stage might result in a smaller share of any deal for CHK1 in the future. SAR could have walked away at the BACIT / CPF deal stage but decided to stay on and pay the 800k and I suspect the payments will be equal in return for equal rewards.

Aurora + FLT3 is a different story. Both are due to start at the end of this year / early next year but from the timescales I've read, it takes much longer for Chinese approval. So I would expect news on this front before CHK1. That should lift the share price too, helping with any possible funding requirements (if needed).

There are lots of possibilities. It will only take one to either get a deal or make it to human trials for the future to look much brighter. And lets not forget, its the science that will be the deciding factor and so far all of the science over the last few years had been good.

Long may that continue
 
PCS1954
Posts: 1,022
Off Topic
Opinion:No Opinion
Price:0.48
View Thread (2)
RE: 50sBoy
8 May '14
Hi Hopkirk as always a balanced resume - my only comment being whilst I accept Sar are equal in partnership they have the "goose" that hopefully is the "golden egg" so the next round of funding I would like to see BACIT take more of a role in raising funds that's a benefit for all - obviously depends on how confident all 3 partners are going into Phase 1 trails, which in itself should lift sp

....and would love to hear update from China......

GLA
Hopkirk
Posts: 1,218
Off Topic
Opinion:No Opinion
Price:0.48
View Thread (2)
50sBoy
8 May '14
Hi. There are still lots of unknowns. If CHK1 gets to Phase 1 trials (not guaranteed but no news is good news at this point), the price should go up as it will a) increase the chances of a deal and b) make the value of that deal more rewarding.

But then there is the question of actually funding the trials. CHK1 will probably cost SAR 1.3m (if they pay the same as BACIT which seems logical to me).

So although applying for trials and then trials starting will be a massive boost for SAR, it opens up more doubt about financing. IMO this is what is keeping it low at the moment - If CHK1 gets to trials, there could be another big placing to raise the cash which could push the SP down to 0.3p. It would be good for the company (in a strange way as it needs to happen and without it the value would go down anyway) but bad for existing shareholders in the short term.

Being more optimistic, the TYK2 results are due soon and Tim is back in San Diego for the recently added Bio International event. Maybe this is a coincidence. Maybe just my wishful thinking. But an early stage deal on this takes away the financing problem.

But until there is more clarity, the questions remain and as long as there is doubt, the price will be low.

So my main questions on CHK1 are:
1. Will trials start (I.e. did pre clinical go ok)
2. How will they be funded
3. What combinations of treatment will be included as this will give us a more acurate idea on just how 'broadly applicable' CHK1 can be.

Fortunately the answers to all of these should be known in 3 to 6 months.

All iMO. GLA
50sBoy
Posts: 341
Off Topic
Opinion:No Opinion
Price:0.48
a thought
8 May '14
I would have thought now that this seems to have settled at this price people would be wanting to be in, so as not to miss the initial surge if as we all hope we have good news.
my thoughts only
LUCAN
Posts: 506
Off Topic
Opinion:No Opinion
Price:0.48
ah, yesterday!
8 May '14
not to worry, probably deserved
CHELSEA7
Posts: 19,391
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.48
LUCAN
8 May '14
Sorry about yesterday, i was rude to you. Apologies
scoopy
Posts: 855
Off Topic
Opinion:No Opinion
Price:0.48
Buys
8 May '14
I bought yesterday at 0.46, so most of them are buys! just couldn't resist another dip into SAR.
LUCAN
Posts: 506
Off Topic
Opinion:No Opinion
Price:0.48
sells
8 May '14
Share trade record this week is terrifying. I think the 47s must be buys, maybe some of the 46s, but even so, an unbroken field of red.
elgouna
Posts: 194
Answer
Opinion:No Opinion
Price:0.48
Paulus47
7 May '14
Any news ,,,are you back ...
eyeofthestorm
Posts: 12
Off Topic
Opinion:No Opinion
Price:0.48
time
7 May '14
Let's be honest. This is the biotechnology industry and anyone who is in here for a quick buck at this time is kidding themselves on. Like everyone else on this board I have invested but I am under no illusion that this is going to mature for a long time. And I don't mean the large spike we had a few years ago, I mean a true value on a priceless product that is being developed to save lives and not just to make us money. Keeping in mind this may never come to anything but I for one am happy to wait up to the 10 years for this to make or break as I strongly believe in this company.





Sign up for Live Prices


Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.